Conatus Pharmaceutic (CNAT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.5560 +0.0010 (+0.18%) 05/26/20 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.5560 unch (unch) -
for Tue, May 26th, 2020
Results
download Want to compare other data? Select Fields| Symbol | CNAT | NEPH | INLF | ||
| Company | Conatus Pharmaceutic | Nephros Inc | Inlif Limited | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.5900 | 1.89 | 1.2100 | ||
| High | 0.5940 | 2.00 | 1.2800 | ||
| Low | 0.5406 | 1.89 | 1.2051 | ||
| Last | 0.5560 | 2.00 | 1.2600 | ||
| Change | +0.0010 | +0.11 | +0.0200 | ||
| % Change | +0.18% | +5.82% | +1.61% | ||
| Volume | 1,696,900 | 2,300 | 22,000 | ||
| 20-Day Average Volume | 3,526,575 | 12,805 | 70,450 | ||
| Previous Close | 0.5550 | 1.89 | 1.2400 | ||
| Industry | Medical Products | Medical Products | Medical Products | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.4899 | 1.81 | 1.5270 | ||
| 20-Day Raw Stochastic | 53.81% | 69.96% | 7.37% | ||
| 20-Day Relative Strength | 60.16% | 59.96% | 42.01% | ||
| Weighted Alpha | +91.81 | +3.24 | N/A | ||
| Today's Opinion | 72% Buy | 72% Buy | N/A | ||
| Previous Opinion | 72% Buy | 72% Buy | N/A | ||
| Last Month's Opinion | 64% Sell | 72% Sell | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -13.80% since 05/18/20 | +6.95% since 04/09/25 | -7.35% since 04/10/25 | ||
| Low | 0.4523 on 05/21/20 | 1.85 on 04/10/25 | 1.1800 on 04/16/25 | ||
| High | 0.7500 on 05/21/20 | 2.05 on 04/14/25 | 1.5200 on 04/11/25 | ||
| 1-Month | |||||
| %Chg | +62.53% since 04/24/20 | +24.11% since 03/17/25 | -27.59% since 03/17/25 | ||
| Low | 0.3300 on 04/28/20 | 1.49 on 03/19/25 | 1.1800 on 04/16/25 | ||
| High | 0.7500 on 05/21/20 | 2.22 on 04/03/25 | 2.5800 on 03/20/25 | ||
| 3-Month | |||||
| %Chg | +35.78% since 02/26/20 | +25.00% since 01/17/25 | -76.54% since 01/17/25 | ||
| Low | 0.2303 on 03/16/20 | 1.39 on 03/03/25 | 1.1800 on 04/16/25 | ||
| High | 0.7500 on 05/21/20 | 2.22 on 04/03/25 | 21.0000 on 02/14/25 | ||
| 6-Month | |||||
| %Chg | +61.35% since 11/26/19 | +33.33% since 10/17/24 | N/A since 01/02/25 | ||
| Low | 0.2303 on 03/16/20 | 1.36 on 10/24/24 | 1.1800 on 04/16/25 | ||
| High | 0.7500 on 05/21/20 | 2.22 on 04/03/25 | 21.0000 on 02/14/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 18,443 | 21,200 | 18,270 | ||
| Shares Outstanding, K | 33,170 | 10,600 | 14,500 | ||
| Annual Sales | 21,720,000 | 14,160,000 | 12,610,873 | ||
| Annual Net Income | -11,390,000 | 70,000 | 1,352,511 | ||
| Last Quarter Sales | 530,000 | 3,870,000 | N/A | ||
| Last Quarter Net Income | -2,730,000 | 350,000 | N/A | ||
| 60-Month Beta | 1.84 | 1.05 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.03 on 03/24/25 | N/A | ||
| Latest Earnings Date | 05/07/20 | 05/08/25 | N/A | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||